希腊中风患者获得最佳医疗技术的情况：给政策制定者的启示

Access of Stroke Patients' to Optimal Healthcare Technology in Greece: Messages to Policy Makers.

作者信息

Siskou Olga, Korompoki Eleni, Ntaios George, Tsampalas Evangelos, Alexopoulou Helen, Kalliontzakis Ioannis, Kouridaki Aspasia, Tountopoulou Argyro, Kouzi Ioanna, Vasilopoulou Sofia, Milionis Haralampos, Evaggelou Hara, Karagkiozi Efstathia, Hatzitolios Apostolos I, Savopoulos Christos, Myrou Athina, Manios Efstathios, Mavraganis Georgios, Vemmou Anastasia, Kaitelidou Daphne, Galanis Petros, Papastefanatos Stefanos, Konstantakopoulou Olympia, Karagkouni Iliana, Vemmos Kostas

机构信息

Center for Health Services Management and Evaluation, Department of Nursing National and Kapodistrian University of Athens, Athens, Greece.

Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.

出版信息

Stud Health Technol Inform. 2020 Jun 26;272:421-424. doi: 10.3233/SHTI200585.

DOI:10.3233/SHTI200585

PMID:32604692

Abstract

The aim of this study was to evaluate accessibility of stroke patients to optimal healthcare technology in Greece. Methods: The study population consisted of 313 first ever stroke patients derived from the "Stroke Units Necessity for Patients, SUN4P" registry. Descriptive statistics were used, to present patients' characteristics and resources utilization Results: The vast majority of patients (91.7%) conducted a CT scan during the acute phase (within the first 24hours). Almost, (65%) were admitted to wards of Internal Medicine Departments, whereas only 21% of patients were admitted to a Stroke Unit. Of note, a total of 6.9% of ischemic stroke patients received intravenous thrombolytic therapy with recombinant tissue plasminogen activator (rtPA). Conclusions: Preliminary results from SUN4P underline the urgent necessity for the re-organization of acute stroke care in Greece, as rates of admissions to stroke units and rtPA treatment during the acute phase are currently below optimal.

摘要

本研究的目的是评估希腊中风患者获得最佳医疗技术的可及性。方法：研究人群包括来自“患者对卒中单元的需求，SUN4P”登记处的313例首次发生中风的患者。采用描述性统计方法呈现患者特征和资源利用情况。结果：绝大多数患者（91.7%）在急性期（头24小时内）进行了CT扫描。近65%的患者被收入内科病房，而只有21%的患者被收入卒中单元。值得注意的是，共有6.9%的缺血性中风患者接受了重组组织型纤溶酶原激活剂（rtPA）静脉溶栓治疗。结论：SUN4P的初步结果突显了希腊重组急性中风护理的迫切必要性，因为目前卒中单元的收治率和急性期rtPA治疗率低于最佳水平。